PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.09%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$166M
AUM Growth
+$166M
(+29%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
13.88%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
82
New
26
Increased
17
Reduced
11
Closed
16
Top Buys
| 1 |
Universal Health Services
UHS
|
$8.71M |
| 2 |
Pfizer
PFE
|
$5.14M |
| 3 |
Stryker
SYK
|
$5.11M |
| 4 |
SPNC
Spectranetics Corp
SPNC
|
$4.28M |
| 5 |
AbbVie
ABBV
|
$4.02M |
Top Sells
| 1 |
Baxter International
BAX
|
$9.93M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$5.3M |
| 3 |
Boston Scientific
BSX
|
$5.03M |
| 4 |
Humana
HUM
|
$4.9M |
| 5 |
CONMED
CNMD
|
$4.72M |
Sector Composition
| 1 | Healthcare | 83.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYNA
26
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.15M | 1.61% |
+194,461
| New | +$3.15M |
|
|
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
| $3.1M | 1.59% |
+120,101
| New | +$3.1M |
|
28
Biogen
BIIB
$20.8B
| $2.95M | 1.51% |
+9,250
| New | +$2.95M |
|
|
QGENF
29
DELISTED
QIAGEN NV
QGENF
| $2.8M | 1.43% |
+100,000
| New | +$2.8M |
|
|
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
| $2.62M | 1.34% |
36,000
+8,350
| +30% | +$608K |
|
|
RCPT
31
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.51M | 1.28% |
11,000
-10,500
| -49% | -$2.39M |
|
|
ASXC
32
DELISTED
Asensus Surgical, Inc.
ASXC
| $2.49M | 1.28% |
762,000
+500,000
| +191% | +$1.64M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.47M | 1.26% |
12,500
+2,500
| +25% | +$494K |
|
34
Accuray
ARAY
$165M
| $2.42M | 1.24% |
+380,000
| New | +$2.42M |
|
|
AGN
35
DELISTED
ALLERGAN INC
AGN
| $2.32M | 1.19% |
+7,000
| New | +$2.32M |
|
|
SGYP
36
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.25M | 1.15% |
246,250
-78,450
| -24% | -$716K |
|
37
Eli Lilly
LLY
$661B
| $2.24M | 1.15% |
+26,500
| New | +$2.24M |
|
|
AKRX
38
DELISTED
Akorn, Inc.
AKRX
| $2.16M | 1.11% |
46,875
-12,125
| -21% | -$559K |
|
|
ADYX
39
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $2.09M | 1.07% |
420,000
+175,000
| +71% | +$872K |
|
40
Catalyst Pharmaceutical
CPRX
$2.42B
| $1.95M | 1% |
395,000
+30,000
| +8% | +$148K |
|
|
SAGE
41
DELISTED
Sage Therapeutics
SAGE
| $1.91M | 0.98% |
+28,000
| New | +$1.91M |
|
42
Tonix Pharmaceuticals
TNXP
$243M
| $1.33M | 0.68% |
157,900
+67,900
| +75% | -$569K |
|
|
FEIC
43
DELISTED
FEI COMPANY
FEIC
| $1.29M | 0.66% |
+15,000
| New | +$1.29M |
|
44
Ironwood Pharmaceuticals
IRWD
$201M
| $1.05M | 0.53% |
+100,000
| New | +$1.05M |
|
|
IPXL
45
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.04M | 0.53% |
+21,543
| New | +$1.04M |
|
|
NDRM
46
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $1.01M | 0.51% |
+53,000
| New | +$1.01M |
|
|
ZGNX
47
DELISTED
Zogenix, Inc.
ZGNX
| $978K | 0.5% |
50,625
-274,375
| -84% | -$5.3M |
|
|
CBAY
48
DELISTED
Cymabay Therapeutics
CBAY
| $602K | 0.31% |
+200,000
| New | +$602K |
|
|
DYAX
49
DELISTED
DYAX CORPORATION
DYAX
| $554K | 0.28% |
+22,500
| New | +$554K |
|
50
Aldeyra Therapeutics
ALDX
$350M
| $511K | 0.26% |
+57,500
| New | +$511K |
|